Study Evaluating PK of Ustekinumab Administered Orally Via RaniPill™ Capsule
Status:
Not yet recruiting
Trial end date:
2024-04-11
Target enrollment:
Participant gender:
Summary
A prospective, single-center, open-label, phase 1 study evaluating the pharmacokinetics (PK)
of ustekinumab administered via the RaniPill™ capsule ("RT-111").